Home›Search›Therapeutic Advances in Cardiovascular Disease

Therapeutic Advances in Cardiovascular Disease

SAGE Publications Ltd · United Kingdom · Est. 1964

ISSN1753-9455

SJR Q2✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.862

H-Indexi

SNIPi

0.895

Total Worksi

532

Total Citationsi

10,975

2yr Mean Citednessi

3.68

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Cardiac & Cardiovascular System; Cardiology and Cardiovascular Medicine; Pharmacology (medical).

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1964

FrequencyBimonthly

StatusActive (last: 2026)

Total Publications532

Publisher OrgSAGE Publishing

OA Since2018

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/11 · 82%

✅

Do you know the journal / publisher?

SAGE Publications Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1753-9455

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

793

2019

283

2020

188

2021

130

2022

158

2023

228

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Cardiac & Cardiovascular System

Scopus Categories

Pharmacology (medical)Cardiology and Cardiovascular Medicine

Research Topics (OpenAlex)

Blood Pressure and Hypertension StudiesHeart Failure Treatment and ManagementAtrial Fibrillation Management and OutcomesCoronary Interventions and DiagnosticsRenin-Angiotensin System StudiesAcute Myocardial Infarction ResearchLipoproteins and Cardiovascular HealthCardiovascular Function and Risk FactorsHormonal Regulation and HypertensionCardiac electrophysiology and arrhythmias

Frequently asked questions about Therapeutic Advances in Cardiovascular Disease

Is Therapeutic Advances in Cardiovascular Disease a predatory journal?

PubScope has no integrity flags on record for Therapeutic Advances in Cardiovascular Disease: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Therapeutic Advances in Cardiovascular Disease?

Therapeutic Advances in Cardiovascular Disease is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.68.

Is Therapeutic Advances in Cardiovascular Disease indexed in Scopus and Web of Science?

Therapeutic Advances in Cardiovascular Disease is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Therapeutic Advances in Cardiovascular Disease?